2m 2m 2m 2m 2m 2m 2m
Us Physical Ther (USPH)
NYSE
$63.50+$0.99 (+1.58%)
Price as of Jun 23, 2026 6:58 PM EDT- $951.3MMarket Cap
- -15.27%1-Year Change
- Medical Care FacilitiesIndustry
Us Physical Ther (USPH)
$63.50+$0.99 (+1.58%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 650.4M -3.12% | 671.3M +11.00% | 604.8M +9.34% | 553.1M +11.74% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 149.7M +20.80% | 123.9M +1.99% | 121.5M +8.47% | 112.0M -4.40% | |
Sales and Marketing Expense | 69.3M +18.82% | 58.3M +12.20% | 52.0M +12.67% | 46.1M -0.91% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 22.4M +19.86% | 18.7M +19.03% | 15.7M +6.46% | 14.7M +27.19% | |
Total Operating Expenses | 631.3M +15.32% | 547.4M +13.27% | 483.3M +9.56% | 441.1M +16.75% | |
Operating Profit | 86.7M +37.12% | 63.2M +21.42% | 52.1M -8.34% | 56.8M -19.60% | |
Interest Income | 105,000 -97.34% | 3.9M +4.43% | 3.8M +339.35% | 859,000 +331.66% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 105,000 -97.34% | 3.9M +4.43% | 3.8M +339.35% | 859,000 +331.66% | |
Total Nonoperating Income and Expense | -8.9M +195.07% | -3.0M +11.88% | -2.7M +118.29% | -1.2M -148.29% | |
Income before Taxes | 77.8M +29.24% | 60.2M +21.94% | 49.4M -11.15% | 55.6M -24.08% | |
Income Taxes | 19.8M +35.59% | 14.6M +20.18% | 12.2M -0.07% | 12.2M -20.35% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 39.6M +25.96% | 31.4M +11.28% | 28.2M -12.19% | 32.2M -21.24% | |
Net Income from Continuing Operations Applicable to Common | 77.8M +29.24% | 60.2M +21.94% | 49.4M -11.15% | 55.6M -24.08% | |
Basic EPS and Net Income | 1.42 -22.83% | 1.84 +43.75% | 1.28 -43.11% | 2.25 -6.64% | |
Diluted EPS and Net Income | 1.42 -22.83% | 1.84 +43.75% | 1.28 -43.11% | 2.25 -6.64% | |
Basic Weighted Average Shares | 15.2M +0.74% | 15.1M +6.17% | 14.2M +9.26% | 13.0M +0.67% | |
Diluted Weighted Average Shares | 15.2M +0.74% | 15.1M +6.17% | 14.2M +9.26% | 13.0M +0.67% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 35.6M -14.00% | 41.4M -72.94% | 152.8M +383.72% | 31.6M +10.60% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 35.6M -14.00% | 41.4M -72.94% | 152.8M +383.72% | 31.6M +10.60% | |
Total Current Assets | 140.0M +1.75% | 137.6M -41.05% | 233.4M +109.75% | 111.3M +16.92% | |
Accumulated Depreciation | 91.2M +4.74% | 87.1M +2.68% | 84.8M +5.76% | 80.2M +7.00% | |
Property and Plant and Equipment and Net | 35.7M +10.92% | 32.1M +23.13% | 26.1M +5.47% | 24.7M +7.70% | |
Total Long-Term Assets | 6.6M +28.88% | 5.2M +82.74% | 2.8M -32.01% | 4.1M +162.93% | |
Total Assets | 1.2B +3.13% | 1.2B +17.07% | 997.2M +16.21% | 858.2M +14.51% | |
Income Taxes Payable | 28.4M -3.65% | 29.5M +18.74% | 24.8M +16.49% | 21.3M +48.09% | |
Total Short-Term Debt | 9.9M -10.31% | 11.0M +43.01% | 7.7M -2.19% | 7.9M +847.35% | |
Total Current Liabilities | 139.0M +19.57% | 116.3M +13.80% | 102.2M +19.53% | 85.5M +2.41% | |
Total Long-Term Debt | 152.6M +7.06% | 142.5M +2.55% | 139.0M -20.95% | 175.8M +49.53% | |
Total Long-Term Liabilities | 3.2M -82.41% | 18.3M +675.68% | 2.4M -81.92% | 13.0M +77.39% | |
Total Liabilities | 433.8M +6.22% | 408.4M +18.38% | 345.0M -7.65% | 373.6M +25.79% | |
Retained Earnings | 227.2M -0.02% | 227.3M +1.56% | 223.8M -3.94% | 232.9M +3.81% | |
Total Stockholders Equity | 476.4M -2.56% | 488.9M +2.67% | 476.2M +50.79% | 315.8M +6.83% | |
Total Shares Outstanding | 17.4M +0.63% | 17.3M +0.62% | 17.2M +13.05% | 15.2M +0.60% | |
Cash Flow | |||||
Cash from Operating Activities | 75.1M +0.16% | 74.9M -8.59% | 82.0M +40.04% | 58.5M -23.39% | |
Capital Expenditures | 14.1M +53.18% | 9.2M -1.16% | 9.3M +12.68% | 8.2M +0.57% | |
Cash from Investing Activities | -36.7M -75.43% | -149.4M +232.00% | -45.0M -44.61% | -81.3M -34.53% | |
Dividends Paid | 27.4M +3.10% | 26.5M +10.00% | 24.1M +13.17% | 21.3M +13.62% | |
Cash from Financing Activities | -44.1M +19.44% | -37.0M -143.85% | 84.3M +227.14% | 25.8M -40.62% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | 13.33% +41.53% | 9.42% +9.39% | 8.61% -16.17% | 10.27% -28.05% | |
Return on Assets | 3.34% +14.98% | 2.90% -4.62% | 3.04% -23.92% | 4.00% -34.16% | |
Return on Equity | 8.20% +25.93% | 6.51% -8.68% | 7.13% -32.21% | 10.52% -26.35% | |
Revenue Growth | -3.12% -128.32% | 11.00% +17.81% | 9.34% -20.46% | 11.74% -31.08% | |
Current Ratio | 1.01 -14.91% | 1.18 -48.19% | 2.28 +75.47% | 1.30 +14.17% | |
Cash Ratio | 0.26 -28.09% | 0.36 -76.22% | 1.50 +304.65% | 0.37 +8.01% | |
Debt-to-Equity Ratio | 0.34 +8.60% | 0.31 +1.95% | 0.31 -47.05% | 0.58 +45.21% | |
Debt-to-Assets Ratio | 0.13 +2.59% | 0.13 -10.61% | 0.15 -31.29% | 0.21 +35.51% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow